An2 Therapeutics, Inc. · NASDAQ:ANTX
Vivo Opportunity Fund Holdings, L.P. reported a 8.00% stake in An2 Therapeutics, Inc. (Schedule 13G)
Event Mar 10, 2026 · Filed Mar 13, 2026
Vivo Opportunity Fund Holdings, L.P. reported a 8.00% stake in An2 Therapeutics, Inc., 2,864,346 shares, as a passive investor on Mar 10, 2026. Filed Mar 13, 2026 (Schedule 13G).
- Stake
- 8.00%
- Shares
- 2,864,346
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 8.00% | 2,864,346 |
| Vivo Opportunity, LLC | 8.00% | 2,864,346 |
| Vivo Opportunity Cayman Fund, L.P. | 0.80% | 289,294 |
| Vivo Opportunity Cayman, LLC | 0.80% | 289,294 |